HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 121-132 of 1,979
Drug study icon
WithdrawnNCT00512616

A Glutamate Transporter GLT1, in the Treatment of Bipolarity

Official study title

An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression

This study was withdrawn before enrollment.

In Bethesda
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT00606229

Safety and Efficacy of Long-term Administration of Aripiprazole for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Aripiprazole for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Chugoku Region
BipolarityMedication studyAges 18–65
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
CompletedNCT00606320

Safety and Efficacy of Extended Administration of Aripiprazole for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Aripiprazole for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Hong Kong
BipolarityMedication studyAges 18–65
Countries
China, Japan, South Korea, + 1 other
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
CompletedNCT00606177

A Investigative Extension study of the Safety and Efficacy of Aripiprazole in the Treatment of people with Bipolarity Experiencing a Manic or Mixed Episode

What is this study about?

Researchers compared Aripiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Hong Kong
BipolarityMedication studyAges 18–65
Countries
China, Japan, South Korea, + 1 other
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
CompletedNCT00606281

A Parallel Group-comparison study of Aripiprazole in the Treatment of people with Bipolarity Experiencing a Manic or Mixed Episode

What is this study about?

Researchers compared Aripiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Hong Kong
BipolarityMedication studyAges 18–65
Countries
China, Japan, South Korea, + 1 other
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Other study type icon
CompletedNCT03017781

The Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolarity

Official study title

An Observational Longitudinal Study in Offspring of Parents With Bipolar Disorder to Evaluate the Relationship of Impairment in Psychosocial Functioning With the Manifestation of Mood Symptoms Over 24 Months

This study has finished and is no longer accepting participants.

Multiple locations, including Culver City
BipolarityObservational studyAges 15–25
Countries
United States
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedNCT00490971

Effectiveness of Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Bipolarity

What is this study about?

Researchers compared Paliperidone ER, placebo and Olanzapine to find out how the approaches affected how long people remain free of a new mood episode in people with bipolarity type I.

This study has finished and is no longer accepting participants.

Multiple locations, including Scottsdale
BipolarityMedication studyAges 18–65
Countries
United States, France, Bulgaria, + 13 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00309699

Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity

What is this study about?

Researchers compared Paliperidone ER, placebo and Quetiapine to find out how the approaches affected manic symptoms in people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
BipolarityMedication studyAges 18–65
Countries
United States, Greece, Lithuania, + 5 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.